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Abstract We have developed an efficient route for the
synthesis of 15N(7)-labeled adenosine as phosphoramidite
building block for site- and atom-specific incorporation
into RNA by automated solid-phase synthesis. Such
labeled RNA is required for the evaluation of selected non-
canonical base pair interactions in folded RNA using NMR
spectroscopic methods.
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Introduction
Numerous reports on the synthesis of atom-specific 15N-
labeled nucleosides exist in the literature; however, pro-
cedures for efficient access to the corresponding
phosphoramidites for RNA solid-phase synthesis are rare
[1–3]. We have recently described our preferred synthetic
routes for 15N(1)-adenosine, 15N(1)-guanosine, 15N(3)-
uridine, and 15N(3)-cytidine phosphoramidites which
allow base pair-specific labeling in RNA for direct mon-
itoring of Watson–Crick base pairs by 1H/15N/15N-COSY
experiments [4]. The approach of individual Watson–
Crick base pair labeling is particularly useful for the
analysis of conformationally flexible RNAs when com-
peting and interconverting secondary structures are
encountered [5, 6].
Along the same line, the evaluation of more complex
base pair interactions such as base triplets or quartets,
and the underlying dynamics in solution is important to
understand functional RNA structures. Thereby, selec-
tive nucleobase labeling is again advantageous for
NMR spectroscopic investigations to directly spot the
interaction of interest which in many cases involves the
Hoogsteen face of one or more purine nucleosides. This
is especially true for larger functional RNAs with
complex folding, such as riboswitch aptamer domains
and ribozymes, where spectral crowding can make the
assignment procedure very labor-intensive or even
impossible. Here, we present an optimized procedure to
synthesize 15N(7)-labeled adenosine phosphoramidite.
Additionally, a potential application to probe a cis
Watson–Crick/Hoogsteen base pair interaction [7] is
demonstrated for a base triplet that has been observed
in the crystal structure of the env22 twister ribozyme
[8].
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Results and discussion
To achieve 15N(7)-labeled adenosine amidite 12, we con-
ceived a strategy that employs a silyl-Hilbert-Johnson
nucleosidation [9–11] and a recently introduced azido-to-
acetamido purine transformation [4] as key steps. There-
fore, 15N(7)-hypoxanthine 5 was synthesized following the
protocol by Jones and coworkers (Scheme 1) [12]. We
started with sodium ethoxide-mediated cyclization of
thiourea and ethyl cyanoacetate to form 6-amino-2-mer-
capto-pyrimidone (1) in high yields [13]. Nitrosylation of
compound 1 installed the 15N-label by electrophilic sub-
stitution using the cost-effective isotope source Na15NO2 in
aqueous acid. The deep red nitroso compound 2 precipi-
tated and was directly reduced to the colorless diamino
mercapto pyrimidone 3 with dithionite [12]. Subsequent
desulfurization with activated nickel sponge in dilute
aqueous ammonia yielded compound 4 [12]. Treatment
with formic acid and diethoxymethyl acetate at elevated
temperature resulted in formation of the imidazo moiety to
furnish the desired 15N(7) hypoxanthine 5 [12]. In our
hands, the 5-step reaction sequence proceeded in 75%
overall yield and was conducted at multigram scales
without the need for chromatographic purifications.
The nucleosidation reaction of 15N(7)-hypoxanthine 5
with 1-O-acetyl-2,3,5-tri-O-benzoyl-ß-D-ribofuranose
under Vorbru¨ggen conditions proceeded in the presence of
N,O-bis(trimethylsilyl)acetamide and trimethylsilyl triflate
to give tribenzoylated 15N(7) inosine 6 as the major pro-
duct, isolated after column chromatography in 56% yield.
N1-, N3-, N7-, and/or O6-glycosylated isomers form as
byproducts in minor amounts, consistent with previous
reports [10, 11] and in accordance to the qualitative
comparison of H-C8 1H NMR resonances observed in the
product mixture (Supplementary Material). The integrity
(C10–N9 connectivity) of compound 6 was further sup-
ported by NMR spectroscopic comparison of 6 with an
authentic sample that was prepared by direct benzoylation
of commercial inosine (Supplementary Material). Next, we
activated the carbonyl group of compound 6 in analogy to a
procedure that was originally developed by Wan and co-
workers [14–16] for the mild activation of cyclic amides
with (benzotriazol-1-yloxy)tris(dimethylamino)phospho-
nium hexafluorophosphate (BOP). Thereby, O6-
(benzotriazol-1-yl)inosine is formed which can be substi-
tuted by a nucleophilic displacement (SNAr) reaction.
These compounds can either be isolated [17] and used as
convertible nucleosides after incorporation into DNA
through solid-phase synthesis or directly derivatized with
an appropriate electron-rich nucleophile [14–16]. For our
route (Scheme 2), we used sodium azide to substitute the
benzotriazolyl inosine intermediate. In the presence of
Cs2CO3, this reaction proceeded smoothly in DMF to yield
the 6-azido purine nucleoside 7 in 70% yield. Compound 7
was then reduced with thioacetic acid, resulting directly in
the N6-acetyl protected 15N(7) adenosine 8 in 84% yield.
Then, selective deprotection of the ribose benzoyl groups
was achieved in close to quantitative yield by treatment
with aqueous NaOH in ethanol and pyridine. Functional-
ization of nucleoside 9 as building block for RNA solid-
phase synthesis started with the introduction of a 4,40-
dimethoxytrityl group on the ribose 50-OH to give com-
pound 10 (59% yield), followed by tert-butyl-
dimethylsilylation of the ribose 20-OH to furnish compound
11 (51% yield). Finally, phosphitylation was executed
with 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite
Scheme 1 
(a) 1.1 equiv. Na15NO2 in aqueous hydrochloric acid, 0 °C, 7 h, 89 %; (b) 2.4 
equiv. Na2S2O4 in aqueous NaHCO3, 0 °C, 7 h, 95 %; (c) 10 % activated nickel 
sponge in 5 % aqueous ammonia, reflux, 2.5 h, 99 %; (d) i) formic acid, reflux, 
ii) 1.2 equiv. formic acid, 2 equiv. diethoxymethyl acetate, in DMF, 130 °C, 2.75 
h, 91 %. 
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(CEP-Cl) in the presence of N,N-diisopropylethylamine in
CH2Cl2. Starting with the nucleosidation reaction of
15N(7)
hypoxanthine 6, our route provides building block 12 in a
10% overall yield in seven steps and with six chromato-
graphic purifications; in total, 1.6 g of 12 was obtained in
the course of this study.
Our motivation to synthesize 15N(7) adenosine phos-
phoramidite 12 refers to the structural distinctions that have
been found recently in the crystal structures of the twister
ribozyme [8, 18–20]. Interestingly, while in the O. sativa
twister ribozyme, the phylogenetically highly conserved
four-base pair stem P1 was formed as predicted [18], in the
env22 ribozyme; only two base pairs of stem P1 were
observed; two nucleotides (U1 and U4) fold back to the
core of the ribozyme and were involved in triplet interac-
tions [8, 19]. One of these triplets (U4A49-A34) very close
Scheme 2 
(a) 1 equiv. 1-O-acetyl-2,3,5-O-benzoyl ribofuranose, 3 equiv. N,O-
bis(trimethylsilyl)acetamide, 3 equiv. trimethylsilyl triflate in toluene, reflux, 75 
min, 56 %; (b) i) 2 equiv. (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium 
hexafluorophosphate (BOP), 2 equiv. Cs2CO3, ii) 2 equiv. NaN3 in DMF, room 
temperature, 2.5 h, 70 %; (c) 6 equiv. thioacetic acid, 5 equiv. 2,6-lutidine in 
dichloromethane, room temperature, 21 h, 84 %; (d) i) 10 equiv. NaOH in 
H2O/pyridine/EtOH, 0 °C, 40 min, ii) Dowex 50WX-8, 95 %; (e) 0.15 equiv. 4-
(dimethylamino)pyridine, 1.15 equiv. 4,4'-dimethoxytrityl chloride (DMT-Cl) in 
pyridine, room temperature, 7.5 h, 59 %; (f) i) 2.2 equiv. pyridine, 1.6 equiv. 
AgNO3 in tetrahydrofuran, room temperature, 30 min, ii) 1.75 equiv. tert-
butyldimethylsilyl chloride (tBDMS-Cl), 4 h, 40 %; (g) 0.5 equiv. 1-
methylimidazole, 4 equiv. N,N-diisopropylethylamine, 2.5 equiv. 2-cyanoethyl 
N,N-diisopropylchlorophosphoramidite (CEP-Cl) in dichloromethane, room 
.%09,h2,erutarepmet
The synthesis of 15N(7)-Hoogsteen face-labeled adenosine phosphoramidite for solid-phase RNA… 151
123
to the active site of the ribozyme (Fig. 1) can be considered
to affect the active site conformation to support phospho-
diester cleavage. It was this base triplet that we intended to
verify in solution by direct monitoring of the A49-
N(7)HN(3)-U4 hydrogen bond interaction, applying HNN
COSY NMR experiments. We, therefore, resorted to the
same bimolecular twister RNA construct that we previ-
ously designed for pKa determination of the putative
general acid A6 at the cleavage site [19]. This time, how-
ever, the RNAs were synthesized with 15N(3)-labeled U4
and 15N(7)-labeled A49.
Indeed, in the HSQC NMR spectra, a resonance
appeared at 161.5 ppm in the presence of saturating con-
centration of Mg2?, indicating the reduced exchange of the
H-15N(3)-U4 with the solvent and thereby supporting a
defined base pair interaction. Unfortunately, our attempts
to verify this interaction directly by a correlation signal
between H-15N(3)-U4 and 15N(7)-A49 in the HNN COSY
experiments failed so far [21, 22]. The 15N(3) chemical
shift value observed for U4 (158.8 ppm) is in the typical
ppm range (between 155 and 165 ppm) of Watson–Crick
UA, trans Watson–Crick/Hoogsteen UA, and also wobble
UG pairs that were observed also in other RNAs
[21, 23, 24]. The H-15N(3)-U4 chemical shift value
observed for U4 (11.92 ppm) is slightly higher compared
to typical H-15N(3)-U shifts in GU wobble base pairs
(11.5–11.8 ppm) but also not in the typical range of
reversed Hoogsteen AU pairs (12.5–13.0 ppm)
[21, 23, 24]. At this time, we, therefore, cannot completely
exclude alternative U4G53 wobble base pair formation
within stem P1 in solution although we favor the view of a
preference for triplet formation. Further experiments and
experimental designs are needed to answer this particular
question in the context of twister ribozyme folding.
Conclusion
Wedeveloped a robust synthesis of a 15N(7)-adenosine building
block for automated RNA solid-phase synthesis. The labeled
nucleosidewas generated via a silyl-Hilbert-Johnson reaction of
15N(7)-hypoxanthine and protected ribofuranose. To transform
the resulting inosine to adenosine, the reaction sequence inclu-
ded a very mild azido-to-acetamido transformation using
thioacetic acid. To demonstrate a potential application, we
incorporated 15N(7)-adenosine into RNA to probe a specific
base triplet interaction thatwas observed in the crystal structures
of the twister ribozyme by NMR spectroscopy in solution.
Fig. 1 Selective labeling of the
U4A49-A34 base triplet
observed in the crystal structure
of the env22 twister ribozyme
[8, 19]. a Chemical structures of
the base triplet with 15N-labeled
nucleobases to probe the cis
Watson–Crick/Hoogsteen
U4A49 interaction.
b Secondary structure of the
non-cleavable bimolecular
twister ribozyme construct used
for the NMR study (Um: 20-
OCH3 uridine). c HSQC and
HNN COSY NMR spectra;
conditions: c(RNA) = 0.4 mM;
100 mM KCl, 10 mM Na
cacodylate, pH 7.0, H2O/D2O
9/1, 298 K; addition of 2 mM
MgCl2 as indicated
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Experimental
Reagents were purchased in the highest available quality
from commercial suppliers (Sigma Aldrich, Acros) and
used without further purification. Sodium 15N-nitrite (98
atom % 15N) was obtained from Sigma Aldrich. Moisture
sensitive reactions were carried out under argon atmo-
sphere. 1H and 13C spectra were recorded on a Bruker DRX
300 MHz spectrometer. Chemical shifts (d) are reported
relative to tetramethylsilane (TMS) referenced to the
residual proton signal of the deuterated solvent (DMSO-d6:
2.50 ppm for 1H spectra and 39.52 ppm for 13C spectra;
CDCl3: 7.26 ppm for
1H spectra and 77.16 ppm for 13C
spectra). The following abbreviations were used to denote
multiplicities: s singlet, d doublet, t triplet, m multiplet,
b broad. Signal assignments are based on 1H-1H-COSY and
1H-13C-HSQC experiments. MS experiments were per-
formed on a Finnigan LCQ Advantage MAX ion trap
instrumentation (Thermo Fisher Scientific) with an elec-
trospray ion source. Samples were analyzed in the positive-
or negative-ion mode. Reaction control was performed via
analytical thin-layer chromatography (TLC, Macherey–
Nagel) with fluorescent indicator. Spots were further
visualized using cerium molybdate or anisaldehyde stain-
ing reagents. Column chromatography was carried out on




15N(7)-Hypoxanthine 5 (2.00 g, 14.6 mmol) and 7.36 g
1-O-acetyl-2,3,5-O-tribenzoylribofuranose (14.6 mmol)
were suspended in 100 cm3 of dry toluene. N,O-
Bis(trimethylsilyl)acetamide (10.7 cm3, 43.8 mmol) was
added and the suspension refluxed for 30 min upon which a
clear yellow solution formed. At this point 7.9 cm3
trimethylsilyl triflate (43.8 mmol) was added and refluxing
was continued for 45 min. All volatiles were evaporated
and the residue was dissolved in 350 cm3 of dichloro-
methane and 150 cm3 of saturated sodium bicarbonate
solution. The organic layer was washed with 150 cm3 of
brine, dried over Na2SO4, filtered, and evaporated. The
crude product was purified by silica gel column chro-
matography, eluting with 0–5% methanol in
dichloromethane. Compound 6 was obtained as an off-
white foam. Yield: 4.72 g (56%); Rf = 0.20 (MeOH/
CH2Cl2 5:95);
1H NMR (300 MHz, DMSO-d6):
d = 4.64–4.88 (m, 3H, H-C(40), 2 9 H-C(50)), 6.19 (t,
J = 5.9 Hz, 1H, H-C(30)), 6.40 (t, J = 5.3 Hz, 1H,
H-C(20)), 6.57 (d, J = 4.6 Hz, 1H, H-C(10)), 7.41–7.53
(m, 6H, H-C(ar, Bz)), 7.61–7.69 (m, 3H, H-C(ar, Bz)),
7.88–8.00 (m, 7H, H-C(2), H-C(ar, Bz)), 8.38 (d, J1H
15-
N = 12.0 Hz, 1H, H-C(8)), 12.49 (br s, 1H, H-N(1)) ppm;
13C NMR (75 MHz, DMSO-d6): d = 63.25 (C(50)), 70.69
(C(30)), 73.31 (C(20)), 79.31 (C(40)), 86.51 (C(10)), 125.04
(C(ar)), 128.30 (C(ar, Bz)), 128.75 (C(ar, Bz)), 129.29
(C(ar, Bz)), 129.37 (C(ar, Bz)), 133.52 (C(ar, Bz)), 133.89
(C(ar, Bz)), 134.00 (C(ar, Bz)), 139.78 (C(8)), 146.15
(C(2)), 147.89 (C(ar)), 156.39 (C(ar)), 164.50 (CO(Bz)),
164.68 (CO(Bz)), 165.42 (CO(Bz)) ppm; ESI–MS: m/




Compound 6 (4.67 g, 8.03 mmol) was dissolved in 64 cm3
of dry DMF and 5.51 g cesium carbonate (16.9 mmol) and
7.47 g (benzotriazol-1-yloxy)tris(dimethylamino)phospho-
nium hexafluorophosphate (16.9 mmol) were subsequently
added. The yellowish suspension was stirred for 30 min at
room temperature, at which point 1.10 g sodium azide
(16.9 mmol) was added. The reaction mixture was stirred
for another 2 h and then concentrated in vacuo. The
resulting slurry was taken up in 200 cm3 of water and
extracted with four 100 cm3 portions of ethyl acetate. The
combined organic phases were washed twice with half
saturated sodium chloride solution and finally with brine.
The ethyl acetate phase was dried over sodium sulfate and
evaporated. The crude product was purified by silica gel
column chromatography, eluting with 20–60% ethyl
acetate in n-hexane. Yield: 3.39 g white foam (70%);
Rf = 0.50 (ethyl acetate/n-hexane 1:1);
1H NMR
(300 MHz, DMSO-d6): d = 4.70–4.90 (m, 2H, 2 9 H-
C(50)), 4.97–4.99 (m, 1H, H-C(40)), 6.27 (t, J = 5.9 Hz,
1H, H-C(30)), 6.47 (t, J = 10.5 Hz, 1H, H-C(20)), 6.86 (d,
J = 4.4 Hz, 1H, H-C(10)), 7.43–7.50 (m, 6H, H-C(ar, Bz)),
7.59–7.69 (m, 3H, H-C(ar, Bz)), 7.90–7.97 (m, 6H, H-C(ar,
Bz)), 8.96 (d, J1H
15
N = 12.2 Hz, H-C(8)), 10.03 (s, 1H,
H-C(2)) ppm; 13C NMR (75 MHz, DMSO-d6): d = 63.34
(C(50)), 70.74 (C(30)), 73.70 (C(20)), 79.72 (C(40)), 87.12
(C10)), 121.02 (C(ar)), 128.26 (C(ar, Bz)), 128.53 (C(ar,
Bz)), 128.68 (C(ar, Bz)), 128.77 (C(ar, Bz)), 128.92 (C(ar,
Bz)), 129.21 (C(ar, Bz)), 129.41 (C(ar, Bz)), 133.49 (C(ar,
Bz)), 133.94 (C(ar, Bz)), 134.05 (C(ar, Bz)), 136.25 (C(2)),
141.40 (C(ar)), 143.76 (C(8)), 164.50 (CO(Bz)), 164.67




Compound 7 (3.22 g, 5.31 mmol) was dissolved in 50 cm3
of dry dichloromethane and 3.15 cm3 2,6-lutidine
(27 mmol) and 2.45 cm3 thioacetic acid (32 mmol) were
added. The solution was stirred at room temperature for
21 h. All volatiles were evaporated and the residue
dissolved in dichloromethane. The organic layer was
washed with saturated sodium bicarbonate solution, 5%
citric acid, and brine. After drying over Na2SO4 and
evaporation, a dark red oil was obtained. The product was
isolated by silica gel column chromatography, eluting from
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0 to 3% methanol in dichloromethane. Yield: 2.77 g (84%)
of compound 8 as a white foam. Rf = 0.35 (MeOH/CH2Cl2
5:95); 1H NMR (300 MHz, DMSO-d6): d = 2.27 (s, 3H,
C(6)-NHCOCH3), 4.65–4.92 (m, 3H, H-C(4
0), 2 9 H-
C(50)), 6.30 (t, J = 5.9 Hz, 1H, H-C(30)), 6.54 (t,
J = 5.3 Hz, 1H, H-C(20)), 6.68 (d, J = 4. 6 Hz, 1H,
H-C(10)), 7.41–7.52 (m, 6H, H-C(ar, Bz)), 7.61–7.68 (m,
3H, H-C(ar, Bz)), 7.88–7.90 (m, 2H, H-C(ar, Bz)),
7.94–8.00 (m, 4H, H-C(ar, Bz)), 8.53 (s, 1H, H-C(2)),
8.72 (d, J1H
15
N = 12.1 Hz, 1H, H-C(8)), 10.74 (s, 1H, C(6)-
NHCOCH3) ppm;
13C NMR (75 MHz, DMSO-d6):
d = 24.94 (C(6)-NHCOCH3), 63.75 (C(50)), 71.27
(C(30)), 73.61 (C(20)), 79.89 (C(40)), 87.18 (C(10)), 124.43
(C(ar, Bz)), 128.92 (C(ar, Bz)), 129.33 (C(ar, Bz)), 129.88
(C(ar, Bz)), 129.97 (C(ar, Bz)), 134.08 (C(ar, Bz)), 134.48
(C(ar, Bz)), 144.20 (C(8)), 150.43 (C(ar)), 151.94 (C(ar)),
152.43 (C(2)), 165.11 (CO(Bz)), 165.29 (CO(Bz)), 166.02
(CO(Bz)), 169.46 (C(6)-NHCOCH3) ppm; ESI–MS: m/
z = 622.99 ([M ? H]?).
[15N(7)]-N6-Acetyladenosine (9, C12H15N4
15NO5)
Compound 8 (2.77 g, 4.45 mmol) was dissolved in 37 cm3
of pyridine/ethanol 1:1 and cooled in an icebath. Then
46 cm3 of 2 M aqueous sodium hydroxide and ethanol 1:1
was rapidly added and the mixture stirred vigorously for
40 min. The reaction was neutralized with Dowex 50WX-8
(pyridinium form) and filtered. The filtrate was evaporated
to yield a slightly red residue which was triturated under
ether and then dichloromethane. The product was obtained
as an off-white solid. Yield: 1.31 g (95%); Rf = 0.40
(MeOH/CH2Cl2 2:8);
1H NMR (300 MHz, DMSO-d6):
d = 2.26 (s, 3H, C(6)-NHCOCH3), 3.57–3.71 (m, 2H,
2 9 H-C(50)), 3.98 (s, 1H, H-C(40)), 4.19 (s, 1H, H-C(30)),
4.63 (s, 1H, H-C(20)), 6.02 (d, J = 5.1 Hz, 1H, H-C(10)),
8.66 (s, 1H, H-C(2)), 8.71 (d, J1H
15
N = 12.1 Hz, 1H,
H-C(8)), 10.74 (s, 1H, C(6)-NHCOCH3) ppm;
13C NMR
(75 MHz, DMSO-d6): d = 24.92 (C(6)-NHCOCH3), 61.91
(C(50)), 70.95 (C(30)), 74.29 (C(20)), 86.34 (C(40)), 88.26
(C(10)), 124.17, 129.85, 143.42 (C(8)), 150.15, 152.19




Compound 9 (1.27 g, 4.10 mmol) and 75 mg 4-(dimethy-
lamino)pyridine (0.61 mmol) were dried over P2O5 under
high vacuum for 2 h and suspended in 30 cm3 of dry
pyridine. DMT-Cl (1.60 g, 4.71 mmol) was added in four
portions and the resulting solution stirred at room temper-
ature. After 7.5 h, the reaction was quenched with
methanol and all volatiles were evaporated. The residue
was dissolved in dichloromethane and 5% citric acid. The
organic layer was separated and washed with 5% citric
acid, saturated sodium bicarbonate solution, and brine,
dried over Na2SO4, filtered, and evaporated. The product
was isolated by silica gel column chromatography, eluting
with 0–7% methanol in dichloromethane. Yield: 1.49 g
(59%) of compound 10 as a white foam. Rf = 0.50
(MeOH/CH2Cl2 1:9);
1H NMR (300 MHz, DMSO-d6):
d = 2.27 (s, 3H, C(6)-NHCOCH3), 3.25 (d, J = 4.1 Hz,
2H, 2 9 H-C(50)), 3.72 (s, 6H, 2 9 CH3O(DMT)),
4.09–4.14 (m, 1H, H-C(40)), 4.33–4.38 (m, 1H, H-C(30)),
4.75–4.80 (m, 1H, H-C(20)), 5.27 (d, J = 6.0 Hz, 1H, HO-
C(30)), 5.61 (d, J = 5.6 Hz, 1H, HO-C(20)), 6.05 (d,
J = 4.6 Hz, 1H, H-C(10)), 6.80–6.85 (m, 4H, H-C(ar,
DMT)), 7.19–7.27 (m, 7H, H-C(ar, DMT)), 7.35–7.37 (m,
2H, H-C(ar, DMT)), 8.58 (d, J1H
15
N = 12.2 Hz, 1H,
H-C(8)), 8.59 (s, 1H, H-C(2)), 10.70 (s, 1H, C(6)-
NHCOCH3) ppm;
13C NMR (75 MHz, DMSO-d6):
d = 24.95 (C(6)-NHCOCH3), 55.50 (2 9 CH3O(DMT)),
64.29 (C(50)), 70.94 (C(30)), 73.57 (C(20)), 83.88 (C(40)),
86.10, 88.81 (C10)), 113.72 (C(ar, DMT)), 124.27 (C(ar,
DMT)), 127.24 (C(ar, DMT)), 128.28 (C(ar, DMT)),
128.35 (C(ar, DMT)), 130.28 (C(ar, DMT)), 136.09,
136.17, 143.56 (C(8)), 145.41, 150.25, 152.25 (C(2)),




Compound 10 (990 mg, 1.62 mmol) was dissolved in
12 cm3 of dry THF and 0.30 cm3 of dry pyridine
(3.56 mmol). Silver nitrate (440 mg, 2.59 mmol) was
added and the mixture was stirred vigorously for 30 min
in the dark at room temperature. Then, 429 mg tBDMS-Cl
(2.84 mmol) was added and stirring was continued for 4 h
at which point the suspension was filtered through a bed of
Celite and evaporated. After aqueous workup with satu-
rated sodium bicarbonate and brine an off-white foam was
obtained. Silica gel column chromatography, eluting with
30–70% ethyl acetate in hexane, yielded 474 mg of the 20-
O-silyl-isomer 11 (40%), 329 mg of the 30-O-silyl-isomer
(28%), and 209 mg of the starting material was recovered.
Rf = 0.50 (MeOH/CH2Cl2 7:93);
1H NMR (300 MHz,
DMSO-d6): d = -0.13 (s, 3H, Si-CH3), -0.03 (s, 3H, Si-
CH3), 0.75 (s, 9H, Si-C(CH3)3), 2.26 (s, 3H, C(6)-
NHCOCH3), 3.30 (m, 2H, 2 9 H-C(5
0)), 3.72 (s, 6H,
2 9 CH3O(DMT)), 4.12–4.17 (m, 1H, H-C(4
0)), 4.27–4.33
(m, 1H, H-C(30)), 4.89 (t, J = 4.8 Hz, 1H, H-C(20)), 5.20
(d, J = 5.9 Hz, 1H, HO-C(30)), 6.06 (d, J = 4.8 Hz, 1H,
H-C(10)), 6.83–6.86 (m, 4H, H-C(ar, DMT)), 7.20–7.28 (m,
7H, H-C(ar, DMT)), 7.39–7.41 (m, 2H, H-C(ar, DMT)),
8.57 (s, 1H, H-C(2)), 8.59 (d, J1H
15
N = 12.2 Hz, 1H,
H-C(8)), 10.71 (s, 1H, C(6)-NHCOCH3) ppm;
13C NMR
(75 MHz, DMSO-d6): d = -5.30 (Si-CH3), -4.83 (Si-
CH3), 17.80 (Si-C(CH3)3), 24.38 (C(6)-NHCOCH3), 25.53
(Si-C(CH3)3), 54.99 (2 9 CH3O(DMT)), 63.37 (C(5
0)),
70.16 (C(30)), 74.86 (C(20)), 83.53 (C(40)), 85.55, 88.22
(C(10)), 113.13 (C(ar, DMT), 123.53 (C(ar, DMT),126.66
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(C(ar, DMT), 127.65 (C(ar, DMT),127.76 (C(ar, DMT),
129.70 (C(ar, DMT), 135.39 (C(ar)), 142.75 (C(8)), 144.82






Compound 11 (500 mg, 0.689 mmol) was dried over P2O5
under high vacuum for 1 h and dissolved in 7 cm3 of dry
dichloromethane. 1-Methylimidazole (0.03 cm3, 0.34 mmol),
0.48 cm3 N,N-diisopropylethylamine (2.75 mmol), and
0.41 cm3 2-cyanoethyl N,N-diisopropylchloro phospho-
ramidite (1.72 mmol) were added and the resulting
solution was stirred for 2 h at room temperature. The
reaction mixture was diluted with dichloromethane and
washed with saturated sodium bicarbonate solution and
brine. The organic phase was dried over Na2SO4, filtered,
and evaporated. The diastereomeric products were isolated
by column chromatography with 30–80% ethyl acetate/
hexane as eluent. Yield: 610 mg (90%) of compound 12 as
a white foam. Rf = 0.40, 0.35 (ethyl acetate/n-hexane 2:1);
1H NMR (600 MHz, CDCl3): d = -0.21 (s, Si-CH3),
-0.20 (s, Si-CH3), -0.05 (s, Si-CH3), -0.02 (s, Si-CH3),
0.76 (s, Si-C(CH3)3), 1.05 (s, N-CH(CH3)2), 1.06 (s, N–
CH(CH3)2), 1.16–1.20 (m, 2 9 N-CH(CH3)2), 2.27–2.35
(m, 1H, POCH2CH2CN), 2.60 (s, C(6)-NHCOCH3),
2.62–2.68 (m, 1H, POCH2CH2CN), 3.31–3.36 (m, H(b)-
C(50)), 3.54–3.69 (m, H(a)-C(50), 2 9 N–CH(CH3)2), 1H
POCH2CH2CN), 3.78 (s, 2 x CH3O(DMT)), 3.84–3.99 (m,
1H, POCH2CH2CN), 4.36–4.44 (m, 2H, H-C(3
0), H-C(40),
5.03–5.06 (m, 1H, H-C(20)), 6.01–6.08 (2 9 d, 1H,
H-C(10)), 6.80–6.82 (m, 4H, H-C(ar, DMT)), 7.20–7.37
(m, 7H, H-C(ar, DMT)), 7.44–7.48 (m, 2H, H-C(ar, DMT),
8.17–8.22 (2 9 d, J1H
15
N = 11.8 Hz, 1H, H-C(8)), 8.58,
8.59 (2 9 s, 1H, H-C(2)), 8.69 (bs, 1H, C(6)-NHCOCH3)
ppm; 13C NMR (151 MHz, CDCl3): d = -5.02 (Si-CH3),
-4.57 (Si-CH3), 17.99 (Si-C(CH3)3), 18.04 (Si-C(CH3)3),
20.19, 20.23, 20.55, 20.60 (POCH2CH2CN), 24.69, 24.76,
24.81, 24.85, 24.90 (2 9 N-CH(CH3)2, C(6)-NHCOCH3),
25.70, 25.73, 25.78 (Si-C(CH3)3), 43.04, 43.12, 43.49,
43.57 (2 9 N-CH(CH3)2), 55.35 (2 9 CH3O-DMT),
57.67, 57.81, 58.82, 58.93 (POCH2CH2CN), 63.19
(C(50)), 63.33 (C(50)), 72.76, 72.85 (C(30)), 73.34, 73.40
(C(30)),74.76 (C(20)), 75.36 (C(20)), 83.95 (C(40)), 84.29
(C(40)), 86.76 (C(DMT)), 86.90 (C(DMT)), 88.42 (C(10)),
88.66 (C(10)), 113.33 (C(ar, DMT)), 117.42, 117.71
(POCH2CH2CN), 122.16, 122.21, 127.11, 128.02, 128.04,
128.26, 128.37, 130.22, 130.27, 130.30 (C(ar, DMT)),
135.61, 135.65, 135.79, 135.84 (C(ar)), 141.99 (C(8)),
142.01 (C(8)), 144.56, 144.68, 149.25, 151.35 (C(ar)),
152.51 (C(2)), 158.70 (C(6)-NHCOCH3) ppm;
31P NMR
(121.5 MHz, CDCl3): d = 151.5, 149.8 ppm; HRMS: m/z
calculated 927.4366 ([M ? H]?), found 927.4368.
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